HEADER PROTEIN BINDING 02-JUL-01 1JIE TITLE CRYSTAL STRUCTURE OF BLEOMYCIN-BINDING PROTEIN FROM BLEOMYCIN- TITLE 2 PRODUCING STREPTOMYCES VERTICILLUS COMPLEXED WITH METAL-FREE TITLE 3 BLEOMYCIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: BLEOMYCIN-BINDING PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES VERTICILLUS; SOURCE 3 ORGANISM_TAXID: 29309; SOURCE 4 GENE: BLMA; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HB101; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PKKTRP KEYWDS PROTEIN-LIGAND COMPLEX, PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR M.SUGIYAMA,T.KUMAGAI,M.HAYASHIDA,M.MARUYAMA,Y.MATOBA REVDAT 4 04-OCT-17 1JIE 1 REMARK REVDAT 3 24-FEB-09 1JIE 1 VERSN REVDAT 2 18-DEC-02 1JIE 1 REMARK REVDAT 1 06-FEB-02 1JIE 0 JRNL AUTH M.SUGIYAMA,T.KUMAGAI,M.HAYASHIDA,M.MARUYAMA,Y.MATOBA JRNL TITL THE 1.6-A CRYSTAL STRUCTURE OF THE COPPER(II)-BOUND JRNL TITL 2 BLEOMYCIN COMPLEXED WITH THE BLEOMYCIN-BINDING PROTEIN FROM JRNL TITL 3 BLEOMYCIN-PRODUCING STREPTOMYCES VERTICILLUS. JRNL REF J.BIOL.CHEM. V. 277 2311 2002 JRNL REFN ISSN 0021-9258 JRNL PMID 11706014 JRNL DOI 10.1074/JBC.M103278200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Y.KAWANO,T.KUMAGAI,K.MUTA,Y.MATOBA,J.DAVIES,M.SUGIYAMA REMARK 1 TITL THE 1.5 A CRYSTAL STRUCTURE OF A BLEOMYCIN RESISTANCE REMARK 1 TITL 2 DETERMINANT FROM BLEOMYCIN-PRODUCING STREPTOMYCES REMARK 1 TITL 3 VERTICILLUS REMARK 1 REF J.MOL.BIOL. V. 295 915 2000 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.1999.3404 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.MARUYAMA,T.KUMAGAI,Y.MATOBA,M.HAYASHIDA,T.FUJII,Y.HATA, REMARK 1 AUTH 2 M.SUGIYAMA REMARK 1 TITL CRYSTAL STRUCTURES OF THE TRANSPOSON TN5-CARRIED BLEOMYCIN REMARK 1 TITL 2 RESISTANCE DETERMINANT UNCOMPLEXED AND COMPLEXED WITH REMARK 1 TITL 3 BLEOMYCIN REMARK 1 REF J.BIOL.CHEM. V. 276 9992 2001 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.M009874200 REMARK 1 REFERENCE 3 REMARK 1 AUTH T.KUMAGAI,K.MUTA,Y.MATOBA,Y.KAWANO,N.KAMIYA,J.DAVIES, REMARK 1 AUTH 2 M.SUGIYAMA REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY DIFFRACTION STUDIES OF REMARK 1 TITL 2 BLEOMYCIN-BINDING PROTEIN FROM BLEOMYCIN-PRODUCING REMARK 1 TITL 3 STREPTOMYCES VERTICILLUS REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 54 127 1998 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444997008871 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 75.9 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.156 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.160 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 10.900 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1862 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 17018 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.143 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.148 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 11.100 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1592 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 14369 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1868 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 192 REMARK 3 SOLVENT ATOMS : 139 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2199.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 5 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 8949 REMARK 3 NUMBER OF RESTRAINTS : 8738 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 ANGLE DISTANCES (A) : 0.030 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.022 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.050 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.060 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.010 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.040 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1JIE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-JUL-01. REMARK 100 THE DEPOSITION ID IS D_1000013806. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-OCT-99 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : R-AXIS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19023 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 80.3 REMARK 200 DATA REDUNDANCY : 3.480 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 55.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.16900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.250 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PDB ENTRY 1QTO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000, AMMONIUM ACETATE, SODIUM REMARK 280 CACODYLATE, PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.71000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A HOMODIMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -46.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A 33 CB - CG - CD1 ANGL. DEV. = 5.1 DEGREES REMARK 500 ARG A 42 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG A 47 NE - CZ - NH1 ANGL. DEV. = 4.1 DEGREES REMARK 500 ARG A 109 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 ASP B 270 CB - CG - OD1 ANGL. DEV. = 5.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 35 -144.95 -142.88 REMARK 500 ASP A 70 87.11 -152.13 REMARK 500 ASP B 235 -146.13 -130.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BLM B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BLM A 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QTO RELATED DB: PDB REMARK 900 1QTO CONTAINS THE SAME PROTEIN UNCOMPLEXED WITH BLEOMYCIN REMARK 900 RELATED ID: 1ECS RELATED DB: PDB REMARK 900 1ECS CONTAINS THE SIMILAR PROTEIN(BLEOMYCIN RESISTANCE PROTEIN) REMARK 900 UNCOMPLEXED WITH BLEOMYCIN REMARK 900 RELATED ID: 1EWJ RELATED DB: PDB REMARK 900 1EWJ CONTAINS THE SIMILAR PROTEIN(BLEOMYCIN RESISTANCE DETERMINANT) REMARK 900 COMPLEXED WITH METAL-FREE BLEOMYCIN REMARK 900 RELATED ID: 1JIF RELATED DB: PDB REMARK 900 1JIF CONTAINS THE SAME PROTEIN COMPLEXED WITH COPPER(II)-BLEOMYCIN DBREF 1JIE A 1 122 UNP Q53793 Q53793_9ACTO 1 122 DBREF 1JIE B 201 322 UNP Q53793 Q53793_9ACTO 1 122 SEQRES 1 A 122 MET VAL LYS PHE LEU GLY ALA VAL PRO VAL LEU THR ALA SEQRES 2 A 122 VAL ASP VAL PRO ALA ASN VAL SER PHE TRP VAL ASP THR SEQRES 3 A 122 LEU GLY PHE GLU LYS ASP PHE GLY ASP ARG ASP PHE ALA SEQRES 4 A 122 GLY VAL ARG ARG GLY ASP ILE ARG LEU HIS ILE SER ARG SEQRES 5 A 122 THR GLU HIS GLN ILE VAL ALA ASP ASN THR SER ALA TRP SEQRES 6 A 122 ILE GLU VAL THR ASP PRO ASP ALA LEU HIS GLU GLU TRP SEQRES 7 A 122 ALA ARG ALA VAL SER THR ASP TYR ALA ASP THR SER GLY SEQRES 8 A 122 PRO ALA MET THR PRO VAL GLY GLU SER PRO ALA GLY ARG SEQRES 9 A 122 GLU PHE ALA VAL ARG ASP PRO ALA GLY ASN CYS VAL HIS SEQRES 10 A 122 PHE THR ALA GLY GLU SEQRES 1 B 122 MET VAL LYS PHE LEU GLY ALA VAL PRO VAL LEU THR ALA SEQRES 2 B 122 VAL ASP VAL PRO ALA ASN VAL SER PHE TRP VAL ASP THR SEQRES 3 B 122 LEU GLY PHE GLU LYS ASP PHE GLY ASP ARG ASP PHE ALA SEQRES 4 B 122 GLY VAL ARG ARG GLY ASP ILE ARG LEU HIS ILE SER ARG SEQRES 5 B 122 THR GLU HIS GLN ILE VAL ALA ASP ASN THR SER ALA TRP SEQRES 6 B 122 ILE GLU VAL THR ASP PRO ASP ALA LEU HIS GLU GLU TRP SEQRES 7 B 122 ALA ARG ALA VAL SER THR ASP TYR ALA ASP THR SER GLY SEQRES 8 B 122 PRO ALA MET THR PRO VAL GLY GLU SER PRO ALA GLY ARG SEQRES 9 B 122 GLU PHE ALA VAL ARG ASP PRO ALA GLY ASN CYS VAL HIS SEQRES 10 B 122 PHE THR ALA GLY GLU HET BLM A 402 96 HET BLM B 401 96 HETNAM BLM BLEOMYCIN A2 HETSYN BLM N1-[3-(DIMETHYLSULFONIO)-PROPYL]BLEOMYCINAMIDE FORMUL 3 BLM 2(C55 H85 N17 O21 S3) FORMUL 5 HOH *139(H2 O) HELIX 1 1 ASP A 15 THR A 26 1 12 HELIX 2 2 HIS A 55 ASP A 60 1 6 HELIX 3 3 ASP A 70 ARG A 80 1 11 HELIX 4 4 ASP B 215 THR B 226 1 12 HELIX 5 5 HIS B 255 ASP B 260 1 6 HELIX 6 6 ASP B 270 ALA B 279 1 10 SHEET 1 A 8 GLU A 30 GLY A 34 0 SHEET 2 A 8 PHE A 38 ARG A 43 -1 O GLY A 40 N ASP A 32 SHEET 3 A 8 ILE A 46 ARG A 52 -1 O ILE A 46 N ARG A 43 SHEET 4 A 8 PHE A 4 ALA A 13 1 O PRO A 9 N HIS A 49 SHEET 5 A 8 SER B 263 VAL B 268 -1 O SER B 263 N VAL A 10 SHEET 6 A 8 CYS B 315 ALA B 320 1 O CYS B 315 N ALA B 264 SHEET 7 A 8 GLU B 305 ARG B 309 -1 O PHE B 306 N PHE B 318 SHEET 8 A 8 ALA B 293 MET B 294 -1 O ALA B 293 N ARG B 309 SHEET 1 B 8 GLU B 230 GLY B 234 0 SHEET 2 B 8 PHE B 238 ARG B 243 -1 O GLY B 240 N ASP B 232 SHEET 3 B 8 ILE B 246 ARG B 252 -1 O ILE B 246 N ARG B 243 SHEET 4 B 8 PHE B 204 ALA B 213 1 O PRO B 209 N HIS B 249 SHEET 5 B 8 SER A 63 VAL A 68 -1 O SER A 63 N VAL B 210 SHEET 6 B 8 CYS A 115 ALA A 120 1 O CYS A 115 N ALA A 64 SHEET 7 B 8 GLY A 103 ARG A 109 -1 O ARG A 104 N ALA A 120 SHEET 8 B 8 ALA A 93 MET A 94 -1 O ALA A 93 N ARG A 109 SHEET 1 C 8 GLU B 230 GLY B 234 0 SHEET 2 C 8 PHE B 238 ARG B 243 -1 O GLY B 240 N ASP B 232 SHEET 3 C 8 ILE B 246 ARG B 252 -1 O ILE B 246 N ARG B 243 SHEET 4 C 8 PHE B 204 ALA B 213 1 O PRO B 209 N HIS B 249 SHEET 5 C 8 SER A 63 VAL A 68 -1 O SER A 63 N VAL B 210 SHEET 6 C 8 CYS A 115 ALA A 120 1 O CYS A 115 N ALA A 64 SHEET 7 C 8 GLY A 103 ARG A 109 -1 O ARG A 104 N ALA A 120 SHEET 8 C 8 GLY A 98 SER A 100 -1 N GLY A 98 O GLU A 105 SITE 1 AC1 31 LYS A 3 ASP A 32 PHE A 33 PHE A 38 SITE 2 AC1 31 ARG A 47 SER A 51 ARG A 52 ARG A 104 SITE 3 AC1 31 ALA B 259 ASP B 260 ASN B 261 THR B 262 SITE 4 AC1 31 TRP B 265 TYR B 286 ALA B 302 ARG B 309 SITE 5 AC1 31 GLY B 313 CYS B 315 GLU B 322 HOH B 520 SITE 6 AC1 31 HOH B 522 HOH B 533 HOH B 555 HOH B 569 SITE 7 AC1 31 HOH B 571 HOH B 575 HOH B 580 HOH B 592 SITE 8 AC1 31 HOH B 595 HOH B 609 HOH B 628 SITE 1 AC2 33 ALA A 59 ASP A 60 ASN A 61 THR A 62 SITE 2 AC2 33 TRP A 65 TYR A 86 THR A 89 PRO A 101 SITE 3 AC2 33 ALA A 102 ARG A 109 GLY A 113 CYS A 115 SITE 4 AC2 33 HIS A 117 GLU A 122 HOH A 511 HOH A 512 SITE 5 AC2 33 HOH A 513 HOH A 530 HOH A 550 HOH A 556 SITE 6 AC2 33 HOH A 559 HOH A 585 HOH A 603 HOH A 605 SITE 7 AC2 33 HOH A 620 HOH A 621 PHE B 233 PHE B 238 SITE 8 AC2 33 ARG B 247 SER B 251 ARG B 252 GLU B 299 SITE 9 AC2 33 ARG B 304 CRYST1 35.520 83.420 43.240 90.00 104.88 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028153 0.000000 0.007480 0.00000 SCALE2 0.000000 0.011988 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023929 0.00000 MASTER 265 0 2 6 24 0 17 6 0 0 0 20 END